GT199800149A - PARASITICIDE FORMULATIONS. - Google Patents

PARASITICIDE FORMULATIONS.

Info

Publication number
GT199800149A
GT199800149A GT199800149A GT199800149A GT199800149A GT 199800149 A GT199800149 A GT 199800149A GT 199800149 A GT199800149 A GT 199800149A GT 199800149 A GT199800149 A GT 199800149A GT 199800149 A GT199800149 A GT 199800149A
Authority
GT
Guatemala
Prior art keywords
parasiticide formulations
parasiticide
formulations
milbemicine
parasitical
Prior art date
Application number
GT199800149A
Other languages
Spanish (es)
Inventor
Hiep Huatan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9720228.7A external-priority patent/GB9720228D0/en
Priority claimed from GBGB9810143.9A external-priority patent/GB9810143D0/en
Application filed filed Critical
Publication of GT199800149A publication Critical patent/GT199800149A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA INVENCION APORTA UN IMPLANTE SOLIDO QUE COMPRENDE AL MENOS UN COMPUESTO PARASITICIDA QUE PUEDE SER UNA AVERMECTINA O UNA MILBEMICINA QUE TIENE UNA BAJA SOLUBILIDAD ACUOSA Y EXCIPIENTES DE COMPRENSION ENTRE LOS QUE SE INCLUYE UN AGENTE DE RELLENO. LOS IMPLANTES DE ACUERDO CON LA INVENCION SON COMODOS DE ADMINISTRAR Y PROPORCIONAN UNA PROTECCION PROLONGADA FRENTE A PARASITOS.THE INVENTION PROVIDES A SOLID IMPLANT THAT INCLUDES AT LEAST ONE PARASITICAL COMPOUND THAT MAY BE AN AVERMECTIN OR A MILBEMICINE THAT HAS A LOW WATER SOLUBILITY AND EXCIPIENTS OF UNDERSTANDING, INCLUDING A FILLING AGENT. IMPLANTS ACCORDING TO THE INVENTION ARE COMFORTABLE TO ADMINISTER AND PROVIDE A PROLONGED PROTECTION AGAINST PARASITES.

GT199800149A 1997-09-23 1998-09-22 PARASITICIDE FORMULATIONS. GT199800149A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9720228.7A GB9720228D0 (en) 1997-09-23 1997-09-23 Parasiticidal formulations
GBGB9810143.9A GB9810143D0 (en) 1998-05-12 1998-05-12 Parasiticidal formulations

Publications (1)

Publication Number Publication Date
GT199800149A true GT199800149A (en) 2000-03-15

Family

ID=26312302

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199800149A GT199800149A (en) 1997-09-23 1998-09-22 PARASITICIDE FORMULATIONS.

Country Status (13)

Country Link
EP (1) EP1014970A1 (en)
JP (1) JP2001517622A (en)
AP (1) AP9801350A0 (en)
AR (1) AR013509A1 (en)
AU (1) AU9742298A (en)
BR (1) BR9812385A (en)
CA (1) CA2304283A1 (en)
GT (1) GT199800149A (en)
MA (1) MA24655A1 (en)
PA (1) PA8459501A1 (en)
PE (1) PE117199A1 (en)
TN (1) TNSN98175A1 (en)
WO (1) WO1999015166A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP279698A0 (en) * 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
US6645192B2 (en) 1998-09-30 2003-11-11 Ivy Animal Health, Inc. Pellet implant system for immediate and delayed release of antiparasitic drug
AU1556000A (en) * 1999-11-22 2001-06-04 Akzo Nobel N.V. Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
US6953586B1 (en) 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
DE10032878A1 (en) * 2000-07-06 2002-01-17 Bayer Ag Anthelmintics to prevent parasitic infections in humans and animals
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US7918863B2 (en) 2005-06-24 2011-04-05 Conceptus, Inc. Minimally invasive surgical stabilization devices and methods
US20200179273A1 (en) * 2017-06-06 2020-06-11 Merck Sharp & DohmeCorp Long-action implant for treatment of infectious diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240274A3 (en) * 1986-04-03 1990-03-14 Merck & Co. Inc. Avermectins as growth promotant agents
US4847243A (en) * 1987-10-08 1989-07-11 Merck & Co., Inc. Treatment for fescue toxicosis in grazing animals
NZ239370A (en) * 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5411737A (en) * 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device

Also Published As

Publication number Publication date
AP9801350A0 (en) 2000-03-17
CA2304283A1 (en) 1999-04-01
JP2001517622A (en) 2001-10-09
BR9812385A (en) 2000-09-12
AU9742298A (en) 1999-04-12
WO1999015166A1 (en) 1999-04-01
EP1014970A1 (en) 2000-07-05
PE117199A1 (en) 1999-11-20
PA8459501A1 (en) 2000-05-24
MA24655A1 (en) 1999-04-01
TNSN98175A1 (en) 2005-03-15
AR013509A1 (en) 2000-12-27

Similar Documents

Publication Publication Date Title
ES2123323T3 (en) ASSOCIATION OF A COMPOUND WITH ANTIMICROBIAL ACTIVITY (FOR EXAMPLE LIPOAMINOACIDO N, N-OCTANOILGLICINA) AND OF A GLYCEROL MONO-ALKYLETER AND ITS USE AS ANTIMICROBIAL AGENT.
PA8484301A1 (en) PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION
GT199800037A (en) COMBINATIONS FOR SULFONILUREA - GLITAZONE DIABETES.
TR200100931T2 (en) New sustained release oral formulations
PA8554501A1 (en) FUNGICIDE COMPOSITION BASED ON ARILAMIDINE DERIVATIVES AND KNOWN FUNGICAL COMPOUNDS
AR027091A1 (en) DOSAGE FORM OF DRUGS DRIVEN BY A HYDROGEL
ES2162319T3 (en) USE OF THE CLIOQUINOL CHELATING AGENT FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE.
AR012671A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PROPHYLAXIS OF THE CONSTIPATION, THE USES OF SUCH COMPOSITIONS AND THE PROCESSES TO PREPARE THEM
AR084885A2 (en) IMPLANT FOR SUBCUTANEOUS IMPLEMENTATION IN AN ANIMAL
ES2195189T3 (en) BENZONAFTIRIDINES AS BRONCHIAL THERAPEUTIC AGENTS.
DK0994710T4 (en) Pharmaceutical compositions for oral administration comprising a benzylhydrylpiperazine and a cyclodextrin
DE69921318D1 (en) SURFACTANT FOR OUTSIDE SKIN PREPARATIONS AND THESE CONTAINING SKIN PREPARATIONS FOR EXTERNAL USE
GT199800149A (en) PARASITICIDE FORMULATIONS.
CU23241B7 (en) 2-PHENYL-1- (4 (2-AMINOETOXI) -BENZIL) -INDOL IN COMBINATION WITH STROGENS
AR032387A1 (en) DENTIFRICO WITH DOUBLE COMPOUND FOR REDUCTION OF BAD BREATH
CO4700420A1 (en) TRANSDERMIC FORMULATION
NO331082B1 (en) Formulation of kahalalide F, comprising such a formulation, as well as reconstituted solution thereof and use of a diluted reconstituted solution for the manufacture of a medicament for the treatment of cancer
PT1079839E (en) THERAPEUTIC AGENT AGAINST CONSTIPACOES CONTAINING ISOMALTOSIS AS ACTIVE INGREDIENT
AR004077A1 (en) A PARTICULARLY COSMETIC COMPOSITION, AND MORE PARTICULARLY FOR THE PERMANENT DEFORMATION OF KERATINIC FIBERS.
CO4750591A1 (en) INSECT FIGHTING PROCEDURE
ES2191426T3 (en) STABLE COMPOSITIONS THAT INCLUDE LEVOSIMENDAN AND ALGINIC ACID.
DE69207777D1 (en) BODY CARE
ES2196171T3 (en) ANTI-FOOD AGENTS OF TIOXANTENONE LIOFILIZED.
ES2140673T3 (en) HELICOBACTER PYLORI CATALASE BASED IMMUNIZING COMPOSITION.
AR027677A1 (en) A THERAPEUTIC PHARMACEUTICAL COMPOSITION THAT INCLUDES CAMPTOTECHINE AND CYCLOFOSPHAMIDE FOR THE TREATMENT OF CANCER